We are using genetics to better understand the pathophysiological intersect of type-2 diabetes and cardiovascular disease, and to better understand how and in whom statin use may lead to a higher risk of developing type-2 diabetes. This project is funded by the National Institutes of Health.
Other collaborators on this project include Alexis Frazier-Wood, Craig Stump, and Jose Ordovas.